Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tenaya Therapeutics, Inc. - Common Stock (NQ:TNYA)

1.310 -0.040 (-2.96%)
Streaming Delayed Price Updated: 12:21 PM EDT, Sep 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tenaya Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Biofrontera (NASDAQ: 
Via Benzinga
Tenaya Therapeutics Appoints Karah Parschauer, J.D., to Its Board of Directors and Joanna Auch as Senior Vice President of People and Culture
From Tenaya Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Ensysce Biosciences (NASDAQ:ENSC) shares increased by 88.08% to $5.61 during Thursday's regular session. As of 12:30 EST, Ensysce Biosciences's stock is... 
Via Benzinga
Tenaya Therapeutics Announces the Addition of Dr. June Lee to its Board of Directors
From Tenaya Therapeutics, Inc.
Via Business Wire
Tenaya Therapeutics to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference
From Tenaya Therapeutics, Inc.
Via Business Wire
Tenaya Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates
From Tenaya Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers PetVivo Holdings (NASDAQ:PETV) s... 
Via Benzinga
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Novavax Shares React to Reports Of Manufacturing Issues With Its COVID-19... 
Via Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news.... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers NRX Pharmaceuticals (NASDAQ:NRXP... 
Via Benzinga
Tenaya Therapeutics to Present Preclinical Data on Its Gene Therapy Programs at the ESGCT 28th Annual Congress
From Tenaya Therapeutics, Inc.
Via Business Wire
46 Biggest Movers From Yesterday
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’... 
Via Benzinga
Tenaya Therapeutics to Participate in Upcoming Investor and Industry Conferences
From Tenaya Therapeutics
Via Business Wire
48 Biggest Movers From Friday
Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by... 
Via Benzinga
50 Biggest Movers From Yesterday
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 61.9% to close at $9.21 on Wednesday following an announcement from management that the company entered into a... 
Via Benzinga
Tenaya Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates
From Tenaya Therapeutics, Inc.
Via Business Wire
65 Biggest Movers From Yesterday
Gainers AgileThought, Inc. (NASDAQ: AGIL) shares surged 69.4% to settle at $23.53 on Thursday. AgileThought 13D Filings from Chairman, CEO Manuel Senderos Fernández and... 
Via Benzinga
Tenaya Therapeutics to Present at Morgan Stanley 19th Annual Global Healthcare Conference
From Tenaya Therapeutics, Inc.
Via Business Wire
55 Biggest Movers From Yesterday
Gainers Unico American Corporation (NASDAQ: UNAM) shares gained 59% to close at $4.15 on Tuesday. Elys Game Technology, Corp. (NASDAQ: ELYS) rose 43% to close at $6.62 after it... 
Via Benzinga
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2021
Upgrades Canaccord Genuity upgraded the previous rating for Precision Drilling Corp (NYSE: 
Via Benzinga
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
Biotech stocks swayed back and forth before ending the week lower. With earnings news dying down and an empty initial public offerings calendar, it was broader market cues,... 
Via Benzinga
Tenaya Therapeutics Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
From Tenaya Therapeutics, Inc.
Via Business Wire
Tenaya Therapeutics Announces Pricing of Upsized Initial Public Offering
From Tenaya Therapeutics, Inc.
Via Business Wire
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... 
Via Benzinga
61 Biggest Movers From Yesterday
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 124.8% to close at $5.08 on Monday after the company announced a $5 million stock repurchase program.... 
Via Benzinga
Heart Disease Company Tenaya Therapeutics Files For $100M US IPO
Tenaya Therapeutics (NASDAQ: TNYA) is quickstepping into a $100 million NASDAQ debut under the TNYA symbol. The company filed an SEC prospectus on Friday. The biotech... 
Via Benzinga
Topics Regulatory Compliance
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.